Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced the interim clinical results from its ongoing Phase 1/2 first-in-human trial ...

A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by ...

Scientists have reached a major milestone in animal-to-human transplant research as the U.S. Food and Drug Administration has approved the first human clinical trials for kidney transplants from ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

New UK clinical trial rules come into force today, cutting set-up times by more than a quarter and making trial registration ...

Clinical trial sponsors and sites are under pressure to separate hype from reality and identify where AI can deliver real ...

The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- On January 9th, GENEIII reaffirmed its global leadership in ergothioneine ...

A new randomized clinical trial provides some of the clearest evidence to date that what we eat can meaningfully reshape both human health and the health of the planet.

Rapid improvements in artificial intelligence emphasize need for randomized trials ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s secretive drug discovery arm, Isomorphic Labs, is getting ready to ...